Gelteq Signs 3-Year China Distribution Deal With Mana To Expand Nutritional Product Portfolio; Expects To Derive A Minimum Revenue Of ~$1.3M During The Term Of The Agreement

Gelteq Limited ("Gelteq" or the "Company"), a clinical and science based innovator in gel based oral delivery technologies, today announced that it has entered into a three year sales agreement with Shenzhen Mana Health Management Co. Ltd. ("Mana") under which Mana will distribute consumer nutritional products within China using Gelteq's proprietary gel formulation. The agreement represents a significant step forward in expanding Gelteq's nutritional product portfolio in China.

Mana is a well-established distributor of healthcare and wellness products in China with a strong digital presence and a network of offline retail sales channels. This infrastructure provides an existing platform to introduce Gelteq's nutritional formulations to a new and broad consumer base across the country.

Under the agreement, Mana will promote, market, and sell a nutritional formulation primarily focused on sugar lowering across China through its multichannel healthcare network. The agreement also includes minimum annual order volumes during its three-year term which Gelteq expects to derive a minimum revenue of approximately USD $1.3 million during the term of the agreement.

The agreement accelerates Gelteq's strategy to expand its proprietary nutritional formulations in China, one of the world's largest and fastest growing wellness and functional nutrition markets. The agreement also establishes a pathway to introduce additional nutritional products that incorporate Gelteq's proprietary technology.